CASE v7.0 Cardiac Testing System Recall
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
GE Medical Systems Information Technologies Inc is recalling 1,835 units of the CASE v7.0 Cardiac Testing System (Model 3031234-001) due to risk of electrical sparking and potential thermal injury.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on July 11, 2026 and geographically references Worldwide. Its severity classification of "high" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, Devices.
What Happened
GE Medical Systems Information Technologies Inc initiated a voluntary recall after determining that electrical sparking may occur at the printer head if the Electrostatic Discharge (ESD) printer brush becomes dislodged. This can result in charring or discoloration of thermal printer paper, with potential ignition leading to serious thermal injury.
Which Products Are Affected
The recall covers the CASE v7.0 Cardiac Testing System, Model no. 3031234-001, Product Code SU3. A total of 1,835 units are affected. The recall number is Z-2279-2026. Distribution was worldwide, including US Nationwide and the countries of Algeria, Australia, Bangladesh, Cambodia, Canada, Croatia, Denmark, Finland, France, Germany, Greece, Hong Kong, India, Indonesia, Ireland, Italy, Japan, South Korea, Lebanon, Libya, Lithuania, Malaysia, Myanmar, Netherlands, New Zealand, Norway, Philippines, Poland, Qatar, Romania, Saudi Arabia, Senegal, Singapore, South Africa, Spain, Sri Lanka, Sweden, Taiwan, Tanzania, Thailand, Tunisia, Turkey, United Arab Emirates, and United Kingdom.
What You Should Do
Consumers should contact the recalling firm for additional information regarding the recall.
Why This Matters
The defect poses a risk of serious thermal injury from potential ignition of printer paper.
Source
FDA recall Z-2279-2026 (Class II), initiated 2026-04-24, reported 2026-06-10.
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (1,402 characters here).
Similar severity timing
Same severity (high) notices issued closest in time to July 11, 2026.
Frequently Asked Questions
Common questions about this FDA recall.